Navigation Links
Abaxis Reports Financial Performance with Record Revenues for the Second Quarter of Fiscal 2012
Date:10/25/2011

ociated with competing in the human diagnostic market, risks related to the protection of Abaxis' intellectual property or claims of infringement of intellectual property asserted by third parties, risks related to condition of the United States economy and other risks detailed under "Risk Factors" in Abaxis' Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2011 and Abaxis' other periodic reports filed from time to time with the United States Securities and Exchange Commission.  Forward-looking statements speak only as of the date the statements were made.  Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

Financial Tables on Following PagesABAXIS, INC.Condensed Consolidated Statements of Income(In thousands, except per share data)(Unaudited)Three Months EndedSix Months EndedSeptember 30,September 30,2011201020112010Revenues

$
40,025

$
35,277

$
76,028

$
70,230Cost of revenues

18,004

15,527

34,784

30,696Gross profit

22,021

19,750

41,244

39,534Operating expenses:   Research and development

3,008

3,296

6,462

6,374   Sales and marketing

9,335

8,408

18,487

17,041   General and administrative

4,495

2,652

7,914

4,776Total operating expenses

16,838

14,356

32,863

28,191Income from operations

5,183

5,394

8,381

11,343Interest and other income (expense), net

56

757

350

652Income before income tax provision

5,239

6,151

8,731

11,995Income tax provision

1,918

2,402

3,196

4,666Net income

$
3,321

$
3,749

$
5,535

$
7,329Net income per share:  Basic net income per share

$
.15

$<
'/>"/>

SOURCE ABAXIS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Abaxis to Report Second Quarter Fiscal Year 2012 Financial Results Tuesday, October 25, 2011
2. Abaxis, Inc. to Present at CL Kings 9th Annual Best Ideas Conference 2011
3. Abaxis to Present at 2011 Morgan Stanley Global Healthcare Unplugged Conference
4. Abaxis Announces Stock Repurchase Program
5. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2012
6. Abaxis to Report First Quarter Fiscal Year 2012 Financial Results Thursday, July 28, 2011
7. Abaxis to Present at Jefferies 2011 Global Healthcare Conference
8. Abaxis to Present at ThinkEquitys Second Annual Healthcare Conference
9. Abaxis Receives Presidential "E" Award for Exports
10. Abaxis, Inc. Awarded $650,000 from Kansas Bioscience Authority
11. Abaxis, Inc. to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), maker of ... Andrew J. Whelan , President will be interviewed ... Business" at 9am EDT on Wednesday, August 5 th ... http://tunein.com/radio/Money-Matters-Boston-1120-s27548/ Mr. ... the company,s flagship product, ActiPatch Therapy, is achieving in ...
(Date:8/3/2015)... Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today ... 2015 Investor Conference Call and webcast at 4:30 p.m., Eastern ... will cover an update on Merrimack,s progress as well ... press release detailing the information to be discussed on ... August 10. Investors and the general public are invited ...
(Date:8/3/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 3, ... therapeutics for the treatment of cancer, today announced ... team. Debanjan Ray , who ... and alliance management, has been promoted to senior ... to joining CytomX, Mr. Ray held positions as ...
Breaking Medicine Technology:UpTick News Wire Radio Show Will Interview BioElectronics' CEO Andrew Whelan 2Merrimack Pharmaceuticals Announces Timing of Second Quarter 2015 Investor Conference Call 2CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3
... 12 A,groundbreaking study developed by Breastcancer.org reports that ... information and messaging,around breast cancer. This study surveyed ... findings from this research revealed that nearly 30% of ... development was a symptom of,breast cancer, and more than ...
... VRUS ), a clinical stage pharmaceutical company committed ... financial results for the fiscal year ended September 30,2008. At ... cash,equivalents and short term investments. , ... Clevudine , ...
Cached Medicine Technology:New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement 2Pharmasset Reports Fiscal Year End 2008 Financial Results 2Pharmasset Reports Fiscal Year End 2008 Financial Results 3Pharmasset Reports Fiscal Year End 2008 Financial Results 4Pharmasset Reports Fiscal Year End 2008 Financial Results 5Pharmasset Reports Fiscal Year End 2008 Financial Results 6Pharmasset Reports Fiscal Year End 2008 Financial Results 7Pharmasset Reports Fiscal Year End 2008 Financial Results 8Pharmasset Reports Fiscal Year End 2008 Financial Results 9
(Date:8/3/2015)... ... August 03, 2015 , ... ... amputation , AUGUST 3, 2015 – Since winning a South by Southwest® (SXSW®) ... Impossible – an organization whose mission is to develop technology for the sake ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... ® and Navigant Center for Healthcare Research and Policy Analysis show widespread support ... of respondents said they agreed or strongly agreed that the controversial law passed ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... National Forest, to Ahjumawi Lava Springs, California’s northernmost and among its least visited ... untapped ground water aquifers, whose main outflow is at Ahjumawi Lava Springs, part ...
(Date:8/3/2015)... ... 03, 2015 , ... A July 13 article from The Daily Mail titled ... Natural Painkiller That Can Last 'For Five Weeks'" discusses the use of stem ... study showed that harvesting stem cell-rich bone marrow from the hip, known as bone ...
(Date:8/3/2015)... ... August 03, 2015 , ... Dignity Health named Dr. Norris ... Hospital Emergency Room – Gilbert, opening in August. The new facility is licensed ... the West Valley. , “Dr. Baldwin is an excellent leader and will ensure ...
Breaking Medicine News(10 mins):Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 2Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 3Health News:Medicine Lake Aquifer could ease California drought says fresh water advocate Sharon Kleyne – but is this necessary? 4Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3
... to Educate Health Care Stakeholders , ... The Virginia Business Coalition on Health (VBCH) announced ... reform efforts initiated by the Center for Medicare and ... "Never Events" - serious and costly preventable hospital errors. ...
... Consumer Watchdog said the health insurance industry,s support today ... it includes a requirement that every American buy insurance ... self-serving. The proposal amounts only to a customer delivery ... will not solve America,s health care problems and will ...
... BOULDER--The University Corporation for Atmospheric Research (UCAR), working ... organizations, is launching a project this month to ... Africa to help reduce outbreaks of meningitis. The ... vaccination programs more effectively for this deadly disease, ...
... Global Programs Required by New Legislation , ... United BioSource Corporation,s (UBC) Annette Stemhagen, DrPH, FISPE, and ... and Drug Safety Summit held in Washington, DC, on ... Director, CDER, FDA; Jane Axelrad, Associate Director for Policy, ...
... (NYSE:, LLY ) and the International Council of ... Chamber of Commerce Business Civic Leadership Center,(BCLC),s 9th annual ... Lilly and ICN were recognized for their groundbreaking work ... worldwide. A unique voting system landed Lilly and ...
... Nov. 19 Par Pharmaceutical,Companies, Inc. (NYSE: PRX ... distribution agreement with AstraZeneca in the U.S. to market budesonide,inhalation ... for the maintenance treatment of asthma. Par began,shipping 0.25 ... , Full-year US sales ...
Cached Medicine News:Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 2Health News:Virginia Business Coalition on Health Issues Statement of Support for Hospital Improvement 3Health News:Consumer Watchdog Comments on Health Insurer's Self-Serving Support of 'Individual Mandate' 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 2Health News:UCAR weather forecasts aim to reduce African meningitis epidemics 3Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 2Health News:United BioSource Scientists, FDA, and Other Industry Leaders Present to Risk Management and Drug Safety Summit 3Health News:Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center 2Health News:Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center 3Health News:Par Pharmaceutical Begins Shipment of Budesonide Inhalation Suspension Immediately 2
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Straight shafts. Overall length 3.9 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Straight 6 mm platform. McPherson handle. Manufactured in titanium. Overall length 3.3 inches....
Curved shafts and tips with 6.5 mm tying platform. Flat serrated handle with dull finish. Overall length 3.9 inches. Overall length 3.9 inches....
Medicine Products: